Full Sentimag® platform awarded place on 2024 Countess of Chester Framework
Endomag has once again been awarded a place on the Countess of Chester Framework with the full Sentimag® platform, simplifying the process for more UK hospitals to access the gold standard system for all-in-one breast localisation.
The new framework features technologies, including the Magseed® marker and Magtrace® lymphatic tracer, that are deemed to provide significant benefits to clinicians and patients, including:
- Greater ease in adopting technologies that improve the patient experience
- Time and cost savings to the hospital
- A simple and legally compliant procurement route
- Training & support available for equipment purchased from the framework and suppliers
With these technologies being accepted on to the framework, it is yet another example of Endomag’s dedication to improving accessibility to breast cancer care, and follows on from last year’s NICE guidance recommendation for Magtrace and Medical Innovation Briefing for Magseed.